Skip to main content

Ophthalmic Drugs Market Growth & Strategy Framework To 2020

In December 2017, Spark Therapeutics received Food and Drug Administration (FDA) approval for the first gene therapy drug in the ophthalmic market-Luxturna (voretigene neparvovec-rzyl). The drug is indicated for ophthalmic diseases associated with RPE65 gene mutation, such as retinitis pigmentosa and Leber’s congenital amaurosis.

Download Free PDF Sample  - https://www.radiantinsights.com/research/ophthalmic--drugs-market/request-sample

Increasing number of strategic mergers, acquisitions, and collaborations make the market for ophthalmic drugs a highly competitive space. However, there is ample scope for consolidation. Premium services and high-volume ancillary value-added businesses deliver supplementary benefits to customers and attract investments in the market. The reimbursement policies for ophthalmic treatment form a diversifying factor in the market.

Companies are constantly launching new products to expand their product portfolio and to attain higher share. For instance, in July 2019, Bausch & Lomb Incorporated announced launch of Ocuvite, an eye vitamin supplement to strengthen the macula for the U.S. market.

Due to increasing awareness of ophthalmic disorders and surge in the demand of these products, ophthalmic drug manufacturers are expanding their presence in the emerging economies by supporting various awareness campaigns in different regions. For instance, in 2016, Alcon announced their support to a public awareness program, Think About Your Eyes. The company committed USD 4 million to support this initiative and to promote awareness pertaining to vision care.

Browse Full Report With TOC  - https://www.radiantinsights.com/research/ophthalmic--drugs-market

Further key findings from the study suggest:

• Anti-VEGF agents dominated the drug class segment in 2019 and is anticipated to register the fastest CAGR of 6.7% over the forecast period

• Retinal disorder held the largest market share in 2019 due to rising prevalence of diabetic retinopathy

• In 2019, macular degeneration was the largest retinal disorder segment and diabetic retinopathy was the fastest growing segment

• Eye drops held the leading ophthalmic drugs market share in 2019 and is projected to witness the highest CAGR during the forecast period as it is the most preferred form of drug delivery used for treating ocular diseases such as acute allergies, corneal ulcers, and glaucoma

Comments

Post a Comment

Popular posts from this blog

Functional Tea Market is expected to boost the growth of the market over the forecast period.

Functional Tea refers to a series of teas that can contribute to bodily functions. In 2019, the market size of Functional Tea is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. Download Request sample copy -  https://www.innovationmarketresearch.com/market-reports/functional-tea-market/request-sample In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Functional Tea. This report studies the global market size of Functional Tea, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). This study presents the Functional Tea sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sal...
Post a Comment
Read more

What is the degree of competition in the global Self-Organizing Networks in the 5G Era industry?

SON (Self-Organizing Network) technology minimizes the lifecycle cost of running a mobile network by eliminating manual configuration of network elements at the time of deployment, right through to dynamic optimization and troubleshooting during operation. Besides improving network performance and customer experience, SON can significantly reduce the cost of mobile operator services, improving the OpEx-to-revenue ratio and deferring avoidable CapEx. Download Free PDF Sample Copy @  https://www.radiantinsights.com/research/son-self-organizing-networks-in-the-5g-era-2019-2030/request-sample To support their LTE and HetNet deployments, early adopters of SON have already witnessed a spate of benefits - in the form of accelerated rollout times, simplified network upgrades, fewer dropped calls, improved call setup success rates, higher end-user throughput, alleviation of congestion during special events, increased subscriber satisfaction and loyalty, and operational efficiencies -...
Post a Comment
Read more

Asia Pacific Thermoplastic Elastomers Market Current Scenario And Industry Forecasts Till, 2014 - 2025.

China TPE market was the market leader in Asia Pacific with an estimated revenue exceeding USD 2 billion in 2014. The market in the region experiences a high demand for TPU and TPV in automotive and medical applications respectively. Thermoplastics consumption in automotive applications is used as an alternative to alloys and metals owing to favourable government policies. In addition, increasing production of passenger cars is anticipated to further augment the regional market demand from 2015 to 2022. In 2014, Japan constituted for approximately 20% of the overall market share by volume. The market in the region is identified by supportive regulatory regulation spertaining to plastic usage in automotive component applications. In addition, automotive OEMs are dynamically implementing thermoplastics as a substitute for metals to make available automobiles with improved performance and fuel efficiency simultaneously reducing total curb weight of the automobile. Download Free Sample...
Post a Comment
Read more